newsfilter
← Latest News
Business Wire·

Reata Pharmaceuticals Announces Presentations at the International Congress for Ataxia Research 2022

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) ("Reata," the "Company," or "we"), a clinical-stage biopharmaceutical company, today announced that abstracts highlighting clinical data for omaveloxolone and disease education